Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 72.69 -0.55% -0.40
ANIP closed down 0.55 percent on Thursday, September 19, 2019, on 63 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Up
See historical ANIP trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
50 DMA Resistance Bearish -0.55%
1,2,3 Pullback Bullish Bullish Swing Setup -0.55%
Calm After Storm Range Contraction -0.55%
Upper Bollinger Band Walk Strength -0.55%
50 DMA Resistance Bearish -1.68%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.68%
MACD Bullish Centerline Cross Bullish -1.68%

Older signals for ANIP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.
Medicine Chemistry Pharmaceutical Retail Outlets Pharmacology Minnesota Chloroarenes Contract Manufacturing Services Cough Antiemetics Enema Metoclopramide Prolactin Releasers
Is ANIP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 86.96
52 Week Low 36.92
Average Volume 159,708
200-Day Moving Average 66.4092
50-Day Moving Average 74.0358
20-Day Moving Average 68.2935
10-Day Moving Average 71.212
Average True Range 2.993
ADX 37.82
+DI 21.4999
-DI 14.5604
Chandelier Exit (Long, 3 ATRs ) 68.48099999999999
Chandelier Exit (Short, 3 ATRs ) 73.23900000000001
Upper Bollinger Band 75.8161
Lower Bollinger Band 60.7709
Percent B (%b) 0.79
BandWidth 22.030208
MACD Line 0.3646
MACD Signal Line -0.8231
MACD Histogram 1.1877
Fundamentals Value
Market Cap 845.96 Million
Num Shares 11.6 Million
EPS 0.46
Price-to-Earnings (P/E) Ratio 158.02
Price-to-Sales 4.26
Price-to-Book 3.82
PEG Ratio 1.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 75.98
Resistance 3 (R3) 76.15 75.24 75.43
Resistance 2 (R2) 75.24 74.40 75.15 75.24
Resistance 1 (R1) 73.96 73.88 73.51 73.79 75.06
Pivot Point 73.05 73.05 72.82 72.96 73.05
Support 1 (S1) 71.77 72.21 71.32 71.60 70.32
Support 2 (S2) 70.86 71.69 70.77 70.14
Support 3 (S3) 69.58 70.86 69.95
Support 4 (S4) 69.41